Effects of Sodium‐Glucose Cotransporter 2 Inhibitors on 24‐Hour Ambulatory Blood Pressure: A Systematic Review and Meta‐Analysis

BACKGROUND: Sodium‐glucose cotransporter 2 (SGLT2) inhibitors are a novel class of antihyperglycemic agents that improve glycemic control by increasing glycosuria. Additional benefits beyond glucose lowering include significant improvements in seated clinic blood pressure (BP), partly attributed to...

Descripción completa

Detalles Bibliográficos
Autores principales: Baker, William L., Buckley, Leo F., Kelly, Michael S., Bucheit, John D., Parod, Eric D., Brown, Roy, Carbone, Salvatore, Abbate, Antonio, Dixon, Dave L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Systematic Review and Meta‐Analysis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5524106/
https://www.ncbi.nlm.nih.gov/pubmed/28522675
http://dx.doi.org/10.1161/JAHA.117.005686

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5524106/
https://www.ncbi.nlm.nih.gov/pubmed/28522675
http://dx.doi.org/10.1161/JAHA.117.005686

Ejemplares similares